- Subjects who have been diagnosed with type 2 diabetes mellitus by a medical
professional according to the American Diabetes Association guidelines.
- Hemoglobin A1c of ≥7 and ≤10.0% in subjects who are metformin-naive or have not taken
metformin for 2 months or Hemoglobin A1c of ≥6.5 and ≤9.5% in subjects who are
metformin-naïve and are taking SU or DPP-IVi which is washed off or taking metformin
and are willing to discontinue metformin in a 8-week washout period.
- Evidence or history of clinically significant hematological, renal, endocrine (other
than T2DM and hypothyroidism), gastrointestinal, cardiovascular, pulmonary, hepatic,
psychiatric or neurologic disease.
- A waist circumference which makes fitting imto the bore of the MR scanner impossible.
Subjects with history of dry eye, known ocular or systemic disease that affect the sclera